Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Intravascular Brachytherapy Cleared by FDA

By HospiMedica staff writers
Posted on 23 Nov 2000
An investigational drug called tranilast shows promise in preventing restenosis by interfering with the proliferation and migration of smooth muscle cells in the arterial wall and by inhibiting the release of chemical mediators of inflammation. More...
Data from an animal study presented at the European Society of Cardiology in Amsterdam showed support for the antiproliferative effect of the drug.

A massive international trial called PRESTO (Prevention of Restenosis with Tranilast and its Outcomes) enrolling 11,500 patients at more than 450 medical centers in 17 countries is seeking to determine if tranilast can reduce the major adverse events associated with restenosis, such as death, heart attack, and the need for revascularization. All trial patients have completed the treatment phase of the trial. Followup evaluation will continue for another six months. Some patients are being evaluated by angiography while others are being evaluated by intravascular ultrasound.

Tranilast is being developed by SmithKline Beecham (SB, Philadelphia, PA, USA) under license from Kissei Pharmaceutical Co., Ltd. (Tokyo, Japan). "The size and scope of the PRESTO reflects our specific commitment to providing a new treatment option to prevent restenosis and our overall commitment to making significant contributions to the field of cardiology,” said Neil Shusterman, M.D., vice president and director of the cardiovascular therapeutic unit at SB.




Related Links:
SmithKline Beecham

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Wound Irrigation Solution
Prontosan®
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The study is the first to demonstrate a single nanomaterial platform that combines rapid blood clotting, activation of the body’s own latent growth factors, recruitment of bone-forming stem cells and enhanced bone regeneration. (Image Credit: Stef Zingsheim/University of Sydney)

Nanobone Material Activates Natural Repair Signals to Regrow Bone

Cleft lip and palate is a birth defect that affects about 1 in 700 children and occurs when parts of the upper lip or roof of the mouth do not fully fuse during pregnancy. Repairing the resulting jawbone... Read more

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.